MPI NEWS
News
A new local case of vaping-associated lung injury was confirmed on Wednesday, Jan. 8, by the County Health and Human Services Agency.
To date, 43 cases of vaping-associated lung injury have been reported among San Diego County residents, while an additional three cases are under investigation. While there have been no local deaths, all patients had to be hospitalized.
San Diego's public school schools have filed suit against Juul Labs, Inc., the largest U.S. producer of e-cigarettes, accusing the company of deliberately marketing its vaping products to young people, effectively rolling back years of progress made by anti-smoking campaigns.
A 40-page complaint filed in San Diego Superior Court on behalf of the San Diego Unified School District on Tuesday alleges that Juul's product "disrupts the learning environment," causing an increase in student absences due to vaping-related illnesses and hurting the schools "by diverting funding away from learning toward educational campaigns, prevention, and treatment."
SAN DIEGO —
Local controversy over marijuana dispensaries opening near churches took a new turn recently, when a man proposing a dispensary in Rancho Bernardo built a large fence on the property to create a longer walking distance between the business and the church -- hoping to allow the dispensary under city rules.
Dispensaries can’t open within 1,000 feet of churches, parks, schools and other “sensitive uses” under city rules. But the 1,000 feet is measured by “path of travel” instead of a straight line, so the fence could make a key difference.
According to the study, male drivers were more likely to report using marijuana or illicit drugs than female drivers. The people most likely to say they used pot before driving were in the 21-25 age group. The second highest group to report using weed were between the age of 16 and 20, the youngest category of drivers to qualify for a license.
You may have noticed that cannabidiol (CBD) seems to be available almost everywhere, and marketed as a variety of products including drugs, food, dietary supplements, cosmetics, and animal health products. Other than one prescription drug product to treat two rare, severe forms of epilepsy, the U.S. Food and Drug Administration (FDA) has not approved any other CBD products, and there is very limited available information about CBD, including about its effects on the body.